Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the tolerability and safety of subcutaneous Affitope AD01 in patients with mild to moderate Alzheimer's disease. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AFFITOPE AD01

Snippet

Sponsor: Affiris AG | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED